CTOs on the Move

Wenatchee Valley Medical Center

www.wvclinic.com

 
Wenatchee Valley Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Wenatchee Valley Medical Center is based in Wenatchee, WA. You can find more information on Wenatchee Valley Medical Center at www.wvclinic.com
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Satellite Healthcare

Making Life Better for Those Living with Kidney Disease. For nearly 40 years, our mission has remained unchanged. From the patient chair side to the boardroom, this powerful yet practical principle guides our daily clinical work as well as our leadership decisions.

Ucare

UCare is an independent, not-for-profit and dynamic health plan providing health coverage and services to Minnesotans of all ages. Working in partnership with health care providers and community organizations, UCare offers: • UCare Choices and Fairview UCare Choices – Commercial products for individual and family coverage available through MNsure. • UCare for Seniors – Medicare Advantage products for individuals eligible for Medicare. • Minnesota Senior Health Options (MSHO) – Integrates Medical Assistance and Medicare services and payments for people age 65 and older. • Minnesota Senior Care Plus (MSC+) – For people eligible for Medical Assistance age 65 and older. • UCare Connect (a.k.a. Special Needs BasicCare, or SNBC) – For adults with certified disabilities (physical and/or mental illness, certified by state or federal government) ages 18-64 (may remain in SNBC when they turn 65). • EssentiaCare – A new Medicare Advantage product offered in partnership with Essentia Health for Medicare-eligible people in 10 north-central Minnesota counties. • MinnesotaCare and Prepaid Medical Assistance Program – Income-based Minnesota Health Care Programs for individuals and families in Olmsted County. This service will grow May 1, 2017, when UCare begins offering MnCare coverage in 55 counties and Medical Assistance in 38 counties. We`re located in restored warehouse offices in Northeast Minneapolis near major freeways, public transportation sites and convenient retail centers. Our diverse workforce is dedicated to serving Minnesotans in all ages and stages of life with high-quality health care coverage products. For the 7th year in a row, employees voted UCare a Star Tribune Top 150 Workplace, including recognition for workplace excellence. UCare also received a special Communication excellence award. We`re the only company to have earned this honor twice since the rankings began in 2010.

United BioSource Corporation

United BioSource Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Information Technology, Inc.

Medical Information Technology, Inc. (MEDITECH) is engaged in developing, manufacturing and marketing of computer software products for the hospital industry. The wholly owned subsidiary of the Company is Patient Care Technologies, Inc. (PtCT).

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.